Invest Now
Products Pricing Partners Refer & Earn

Platforms

Trading Options

Platforms

Trading Options

Pricing

Trading & Investing

Calculators

Support

Learn

IPO

About Us

Partners

Refer & Earn

Open an account Login

Beryl Drugs Ltd Share Price

₹ 0.00 0 (0%)

Updated on 01-01-1970 5:30 AM

Stock Rating

Pros 0

 

Cons 7

Beryl Drugs Ltd Price Performance

  • Day's Low
  • ₹0
  • Day's High
  • ₹0
₹ 0
  • 52-w low
  • ₹0
  • 52-w high
  • ₹0
0
  • Day's open
    ₹0
  • Previous close
    ₹0
  • VWAP
    ₹0
  • Lower price band
    ₹0
  • Upper price band
    ₹0

Today's Market Action

Its last traded stock price on BSE was 23.32 down by 0.00%. The total volume of shares on NSE and BSE combined was 3,271 shares. Its total combined turnover was Rs 0.01 crores.

Beryl Drugs Ltd Medium and Long Term Market Action

The stock price of Beryl Drugs Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Beryl Drugs Ltd Fundamentals

  • Market Cap (Cr): 11.8

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Beryl Drugs Ltd Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Beryl Drugs Ltd Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About Beryl Drugs Ltd

Data not available.

Beryl Drugs Ltd FAQ's

What is Share Price of Beryl Drugs Ltd?

What is the Market Cap of Beryl Drugs Ltd?

What is PE Ratio of Beryl Drugs Ltd?

What is PB Ratio of Beryl Drugs Ltd?

What is the CAGR of Beryl Drugs Ltd?

How to Buy Beryl Drugs Ltd Share?

Financials

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

  • No Data Available

Cons

  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Poor Cash Flow Conversion
    The business has very poor cash conversion ratio of only 29.71% of operating earnings getting converted into operating cash flow. This implies that increase in profits has not translated into higher cash flows for the business and incrementally higher investments in working capital which works negatively for shareholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 4.29 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Poor Corporate Governance
    The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(25/03/2025)
Stock Valuation
Green line
99
0%
0% People are bullish about Beryl Drugs Ltd
0%
0 % People are bearish about Beryl Drugs Ltd

What is your opinion about this Stock?

Historical Data

Beryl Drugs Ltd

₹ 0 (%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %

      ×

      Filing Complaints on SCORES

      Easy & quick Easy & quick

      1. Register on SCORES portal

      2. Mandatory details for filling complaints on SCORES

      Name | PAN | Address | Mobile | Number | E-mail ID

      3. Benefits

      Effective Communication

      Speedy redressal of the grievances

      Website Icon
      Open Free Account Now

      Open Free Trading & Demat Account

      +91